The eyes are an important component of facial aesthetics. They are in the center of an anatomical area of the face very important for rejuvenation procedures, the so‐called “periorbital region.” The appearance of the eyes therefore decisively influences the perception of the aesthetics and aging of the entire face. In juvenile age, the skin of the periocular area is elastic and tonic, without sun damage; the eyebrow is full, well defined, and not descending; there is a clear and visible fold of the upper eyelid, with minimal dermatochalasis; the lower eyelid is tense and well positioned. The aim of this preliminary study is to define a protocol for the use of plasma technology in the treatment of aging signs of the periorbital region. The protocol is aimed to provide predictable, constant, and safe results.
Vulvovaginal atrophy is a condition that affects women, although it is mainly associated with the onset of menopause mainly due to hormonal changes vulvovaginal laxity and mucosal atrophy can also affect women at different life stages such as after pregnancy or for cancer patients who have undergone chemo or endocrine therapy. This condition negatively influence quality of life, sexual desire, and self‐confidence. Many therapies have been considered mainly with inconclusive or transient results in terms of benefit factor. Recently, a new non‐invasive product, containing hyaluronic acid, oligopeptides, and antioxidants was introduced to the market. Its name is “Primavera,” by Renaissance, Italy. The aim of this product is to allow a vulvo‐vaginal biostimulation and considered simple, safe, and satisfactory.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.